Abstract Search

ea0070ep38 | Adrenal and Cardiovascular Endocrinology | ECE2020

Intracardiac paraganglioma in a patient with a paraganglioma syndrome type 4. Short, medium and long-term follow-up

Chicharro Pablo Lois , Wong Martín Jaime , Basagoiti Carreño Belén , Ferreira Ocampo Pablo José , Almdóvar Ruiz Francisca

Introduction: Paraganglioma type 4 is the second most common hereditary paraganglioma syndrome. It is due to a mutation in the succinate dehydrogenase B (SDHB) gene. Associated with high morbimortality for presenting high penetrance (77%) and debut at an early age with a high probability of malignancy (31–71%). In terms of follow-up, annual biochemical monitoring is recommended for mutation carriers. However, the affected gene should be taken into account, for example: t...

0 shares

ea0073aep211 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Selective sodium-glucose cotransporter inhibitors 2 (isglt2) in patients with high risk of amputation

Mª del Carmen Serrano Laguna , Verónica Ávila Rubio , Sara León Utrero , Pablo José López-Ibarra Lozano

IntroductionThe use of iSGLT2 remains controversial in diabetic patients with peripheral arterial disease.ObjectivesAssess metabolic effect and risk of amputations of iSGLT2 in diabetic patients treated in the Multidisciplinary Unit of Diabetic Foot (MUDF) comparatively with a control group.Design and methodsRetrospective observational study in which the patients ...

0 shares

Endocrine Abstracts

Intracardiac paraganglioma in a patient with a paraganglioma syndrome type 4. Short, medium and long-term follow-up

Selective sodium-glucose cotransporter inhibitors 2 (isglt2) in patients with high risk of amputation

BiosciAbstracts